MYELOFIBROSIS

This adverse event was reported 3027 times

These drugs are most commonly taken by patients reporting MYELOFIBROSIS:

# Drug Count
0 RUXOLITINIB 944
1 HYDROXYUREA 275
2 ASPIRIN 176
3 ASPIRIN 325 MG 168
4 ASPIRIN 81 MG 168
5 ROMIPLOSTIM 157
6 ALLOPURINOL 152
7 FUROSEMIDE 126
8 DEFERASIROX 120
9 ELTROMBOPAG OLAMINE 109
See all common drugs associated with MYELOFIBROSIS

MYELOFIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TIMOLOL HEMIHYDRATE 1 0.0769
1 MOMELOTINIB 96 0.0648
2 ANAGRELIDE HYDROCHLORIDE 41 0.0349
3 ALUMINUM CHLOROHYDRATE 1 0.0222
4 HYDROXYUREA 275 0.0129
5 RUXOLITINIB 944 0.0129
6 DANAZOL 36 0.0127
7 FEDRATINIB HYDROCHLORIDE 17 0.0126
8 PACRITINIB 35 0.0114
9 ROMIPLOSTIM 157 0.0103
See all drugs enriched for association with MYELOFIBROSIS

MYELOFIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 157 0.0103
1 Complement Factor D Inhibitor [EPC] 3 0.0097
2 Interferon alfa-2b [EPC] 17 0.0091
3 Janus Kinase Inhibitor [EPC] 947 0.0059
4 Erythroid Maturation Agent [EPC] 11 0.0042
5 Iron Chelator [EPC] 123 0.0042
6 Kinase Inhibitor [EPC] 1007 0.0018
7 Androgen [EPC] 41 0.0015
8 Xanthine Oxidase Inhibitor [EPC] 164 0.0009
9 CD33-directed Immunoconjugate [EPC] 3 0.0008
See all drug classes enriched for association with MYELOFIBROSIS